SWICS™

K263459 · Bloom Surgical, Inc. · GCJ · Oct 29, 2026 · Gastroenterology, Urology

Device Facts

Record IDK263459
Device NameSWICS™
ApplicantBloom Surgical, Inc.
Product CodeGCJ · Gastroenterology, Urology
Decision DateOct 29, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 876.1500
Device ClassClass 2

Indications for Use

SWICSTM is intended to clean the lens of a laparoscope during laparoscopic procedures.

Device Story

SWICSTM is a sterile, single-use, disposable laparoscope lens cleaner for minimally invasive surgery (MIS). It attaches to a 10 mm laparoscope prior to insertion into a 12 mm trocar. The device features a manual sliding trigger that activates a wiping mechanism and a self-contained irrigation system (supplied via two co-packaged sterile syringes) to remove solid debris and fluids from the distal lens. Used in the operating room by surgical staff, the device allows for intraoperative lens cleaning without removing the laparoscope from the surgical site. This maintains clear, uninterrupted visualization, potentially reducing procedure time and improving surgical outcomes by ensuring the surgeon has a consistent view of the anatomy.

Clinical Evidence

Bench testing only. No clinical data. Testing included sterilization validation (ISO 11135), EO residuals (ISO 10993-7), shelf-life/packaging (ASTM D4169, F2096, F88/F88M), and biocompatibility (ISO 10993-1:2025, including cytotoxicity, sensitization, irritation, acute systemic toxicity, and material-mediated pyrogenicity). Mechanical testing assessed cleaning efficacy, impact, fatigue, shear, loading, corrosion, chemical exposure, and thermal effects.

Technological Characteristics

Single-use, EO-sterilized laparoscopic accessory. Materials: polymer and metal. Dimensions: 10 mm diameter (compatible with 10 mm laparoscopes and 12 mm trocars). Mechanism: manual sliding trigger for mechanical wiping and self-contained fluid irrigation. Standards: ISO 11135 (sterilization), ISO 10993-7 (EO residuals), ISO 10993-1 (biocompatibility), ASTM D4169/F2096/F88 (packaging).

Indications for Use

Indicated for use in patients undergoing laparoscopic procedures to clean the laparoscope lens and maintain visualization.

Regulatory Classification

Identification

An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

Special Controls

*Classification* —(1)*Class II (special controls).* The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

In combination with the general controls of the FD&C Act, the integrated operating table-electromechanical surgical system is subject to the following special controls: 1. (1) Premarket clinical performance testing, or a combination of premarket clinical performance testing and postmarket surveillance (in accordance with special control (2)), must include the following: 1. (i) Objective performance measures (e.g., rate and number of conversions to other surgical modalities, rate of device related adverse events (including tissue injury, hematoma, and increased blood loss), and their severity, cause, and outcomes) must be reported with relevant descriptive comparator performance measures. 2. (ii) The data must demonstrate the performance of the device for providing accurate and precise control of attached surgical instruments in range of clinical conditions relevant to the device's intended use. 3. (iii) The test dataset must include data collected from a patient population representative of the intended patient population under anticipated conditions of use. 2. (2) Data obtained from postmarket surveillance must demonstrate, in consideration of the premarket data obtained in accordance with special control (1), that the device performs in accordance with special control (1), unless FDA determines, based on the totality of the premarket data, that data from postmarket surveillance is not required to demonstrate that the device performs as intended. Such postmarket surveillance must be conducted per a protocol determined appropriate by FDA to demonstrate that the device performs as intended (in consideration of the premarket data obtained in accordance with special control (1)), and must include initiation, enrollment, and reporting requirements to ensure timely periodic updates to FDA on post-market surveillance progress and outcomes. 3. (3) Animal performance testing must evaluate the extent of port site trauma due to repositioning of table during surgical procedures when utilizing robotic minimally invasive and laparoscopic approaches 4. (4) The device manufacturer must develop, and update as necessary, a device-specific use training program that ensures proper device setup/use/shutdown, accurate control of instruments to perform the intended surgical procedures, troubleshooting and handling during unexpected events or emergencies, and safe practices to mitigate use error. 5. (5) The device manufacturer may only distribute the device to facilities that implement and maintain the device-specific use training program and ensure that users of the device have completed the device-specific use training program. (6) Human factors assessment must demonstrate that the user can correctly use the device system across all intended use environments with the provided instructions and training materials, including patient access during normal operating conditions and emergency situations, and effects arising from the integrated nature of the operating table and robotic surgical arms. (7) Labeling must include: (i) A detailed summary of clinical performance testing conducted with the device, including study population, results, adverse events, and comparisons to any comparator groups identified; (ii) A statement in the labeling that the safety and effectiveness for the representative specific procedures was based on evaluation of the device as a surgical tool and did not include evaluation of outcomes related to the treatment of the patient's underlying disease or condition, unless FDA determines that it can be removed or modified based on clinical performance data submitted to FDA; (iii) Identification of compatible devices; (iv) The list of surgical procedures for which the device has been determined to be safe with clinical justification; (v) Reprocessing instructions for reusable components; (vi) A shelf life for any sterile components; (vii) A description of the device-specific use training program; (viii) A statement that the device is only for distribution to facilities that implement and maintain the device-specific use training program and ensure that users of the device have completed the device-specific use training program; and (ix) A summary of any completed postmarket surveillance data collected as required by special control (2), including updated labeling to accurately reflect outcomes observed in postmarket surveillance. (8) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use and must include: (i) Device motion accuracy and repeatability; (ii) System testing; (iii) Instrument reliability; (iv) Crosstalk; (v) Table motion control; (vi) Thermal effects on tissue; (vii) User-device interface performance; (viii) Workspace access testing; and (ix) Performance testing with compatible devices. (9) Software verification, validation, and hazard analysis must be performed. (10) Electromagnetic compatibility and electrical, thermal, and mechanical safety testing must be performed. (11) Performance data must demonstrate the sterility of all patient-contacting device components. (12) Performance data must support the shelf life of the device components provided sterile by demonstrating continued sterility and package integrity over the labeled shelf life. (13) Performance data must validate the reprocessing instructions for the reusable components of the device. (14) Performance data must demonstrate that all patient-contacting components of the device are biocompatible. (15) Performance data must demonstrate that all patient-contacting components of the device are non-pyrogenic. (16) The device manufacturer must submit a report to the FDA annually on the anniversary of initial marketing authorization for the device, until such time as FDA may terminate such reporting, which comprises the following information: (i) Cumulative summary, by year, of complaints and adverse events since date of initial marketing authorization; and (ii) Identification and rationale for changes made to the device, labeling, or device specific use training program, which did not require submission of a premarket notification during the reporting period.

Predicate Devices

Reference Devices

Submission Summary (Full Text)

{1} FDA U.S. FOOD & DRUG ADMINISTRATION Bloom Surgical, Inc. % Roshana Ahmed Principal Consultant Quaras, LLC 2101 Camino Rey Fullerton, California 92833 October 29, 2026 Re: K263459 Trade/Device Name: Swics™ Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope And Accessories Regulatory Class: Class II Product Code: GCJ Dated: September 28, 2026 Received: September 28, 2026 Dear Roshana Ahmed: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Before making any change significantly affecting the safety or effectiveness of the device, you must submit a new premarket notification in accordance with 21 CFR 807.81. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {2} K263459 - Roshana Ahmed Page 2 to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Office of Industry and Consumer Education (OICE) to ask a question about a specific regulatory topic. See the OICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory- {3} K263459 - Roshana Ahmed Page 3 assistance/contact-us-office-industry-and-consumer-education-oice) for more information or contact OICE by email (AskOICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Colin K. Chen -S Digitally signed by Colin K. Chen -S Date: 2026.10.29 21:10:52 -04'00' Colin Chen Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {4} DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration # **Indications for Use** Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2023 See PRA Statement below. 510(k) Number (if known) K263459 Device Name SWICSTM Indications for Use (Describe) SWICSTM is intended to clean the lens of a laparoscope during laparoscopic procedures. Type of Use (Select one or both, as applicable) ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) # **CONTINUE ON A SEPARATE PAGE IF NEEDED.** This section applies only to requirements of the Paperwork Reduction Act of 1995. # **\*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*** The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov *"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."* FORM FDA 3881 (6/20) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF {5} SWICSTM K263459 Bloom Surgical Inc. # 510(k) Summary Date Prepared: October 28, 2026 ## I. Contact Details (21 CFR 807.92(a)(1)) | Applicant Name | Bloom Surgical Inc. | | --- | --- | | Applicant Address | 15 Mario Capecchi Dr. Salt Lake City, UT 84108 United States | | Applicant Contact Telephone | 801-885-8633 | | Applicant Contact | Jacob Sheffield | | Applicant Contact Email | jacob@bloomsurgical.com | | Correspondent Name | QUARAS, LLC | | Correspondent Address | 2101 Camino Rey Fullerton, CA 92833 United States | | Correspondent Contact Telephone | 657-248-7361 | | Correspondent Contact | Roshana Ahmed | | Correspondent Contact Email | rahmed@quarasconsulting.com | ## II. Device Name (21 CFR 807.92(a)(2)) | Device Trade Name | SWICSTM | | --- | --- | | Common Name | Endoscope and accessories | | Classification Name | Laparoscope General & Plastic Surgery | | Regulation Number | 876.1500 | | Product Code(s) | GCJ | ## III. Legally Marketed Predicate Devices (21 CFR 807.92(a)(3)) | Predicate 510(k) | Predicate Trade Name | Product Code | | --- | --- | --- | | K260710 | Clear-Vu System | OCT | | K200228 | ClearCam System | GCJ | Page 1 of 4 {6} SWICSTM K263459 Bloom Surgical Inc. #### IV. Device Description (21 CFR 807.92(a)(4)) SWICSTM is a sterile, single-use, disposable laparoscope lens cleaner designed to maintain clear and uninterrupted in-abdomen visualization during minimally invasive surgeries (MIS). Attached to the laparoscope prior to insertion of the device into the laparoscopic port, SWICSTM enables cleaning of the lens directly at the surgical site via use of a sliding trigger. The product features a wiping mechanism combined with a self-contained irrigation system that effectively cleans the lens by removing solid debris and fluids. SWICSTM is offered in the following configuration: - 10 mm, 0°; designed to fit 10 mm, 0° laparoscopes and 12 mm trocars The product is co-packaged with two (2) sterile syringes which are used to transfer the selected cleaning fluid to the SWICSTM reservoir. #### V. Intended Use/ Indications for Use (21 CFR 807.92(a)(5)) SWICSTM is intended to clean the lens of a laparoscope during laparoscopic procedures. #### VI. Indications for Use Comparison (21 CFR 807.92(a)(5)) There are slight differences between the subject and predicate device indications for use statements; however, the differences do not alter the intended use of the subject device when compared to the predicate device. All three devices are laparoscope accessories intended to restore or maintain visualization of the surgical site by cleaning the laparoscope lens during surgical procedures. #### VII. Technological Comparison (21 CFR 807.92(a)(6)) The SWICSTM, Clear-Vu System (K080613), and ClearCam System (K200228) are all single-use, EO sterilized, laparoscopic accessories that utilize a clear polymer sheath that interfaces with the laparoscope and provides a mechanism to clear the distal lens. The SWICSTM configuration subject of this 510(k) is designed to be compatible with 10 mm laparoscopes and 12 mm trocars. Each device mounts onto the laparoscope by sliding a sheath over the scope until a defined feature arrests motion, and each includes a user-operated interface designed for intraoperative use in the operating room. The SWICSTM combines two well-established lens-clearing modalities: - fluid delivery to the distal lens for cleaning similar to the Clear-Vu System (K080613). Page 2 of 4 {7} SWICSTM K263459 Bloom Surgical Inc. - a manual mechanism to physically remove fluid and debris from the lens similar to the ClearCam System (K200228). The differences between the subject and predicate devices are limited to implementation details of fluid supply/pressurization, wiper power transmission, and certain mounting/securement features: - Irrigation supply and pressure source - The SWICSTM utilizes an internal source to deliver cleaning fluid whereas the Clear-Vu System (K080613) relies on connection to a surgical irrigation system. - Wiper mechanism and power transmission - The SWICSTM provides lens cleaning and clearing via a manual mechanical wiping mechanism whereas the ClearCam System (K200228) provides clearing via a manual wiper actuated by a metallic wire through the sheath. - Mounting and securing methods - The subject and predicate devices mount via sheath placement and are secured to the laparoscope using proximal features (clamps/compression). The SWICSTM is secured to the laparoscope via the light port and the scope body. - Materials - The SWICSTM is manufactured from polymer and metal, consistent but not identical to the materials used in the predicate devices. The SWICSTM and identified predicate devices have the same intended use and the SWICSTM combines the technological features of the Clear-Vu System (K080613) and ClearCam System (K200228). The technological differences between the subject device and the predicate devices do not raise different questions of safety and effectiveness and non-clinical testing demonstrates that these differences do not alter the safety or performance of the subject device when compared to the predicate devices. Therefore, the SWICSTM is substantially equivalent to the Clear-Vu System (K080613) and ClearCam System (K200228). ### VIII. Non-Clinical Test Summaries and Conclusions (21 CFR 807.92(b)) The following performance data were submitted in support of a demonstration of substantial equivalence: - Sterilization validation per ISO 11135 and evaluation of EO residuals per ISO 10993-7. - Shelf-life and packaging validation per ASTM D4169 including package integrity testing per ASTM F2096 and ASTM F88/F88M. Page 3 of 4 {8} SWICS™ K263459 Bloom Surgical Inc. - Biocompatibility • An evaluation of biological safety was undertaken in accordance with ISO 10993-1:2025. The following tests were conducted: cytotoxicity per ISO 10993-5:2009, sensitization per ISO 10993-10:2021, irritation per ISO 10993-23:2021, acute systemic toxicity per ISO 10993-11:2017, and material-mediated pyrogenicity per USP <151>. - Mechanical testing including assessments of cleaning efficacy, impact tests, fatigue and shear tests, loading tests, corrosion, chemical exposure, and thermal effects. Data from the non-clinical tests demonstrate that the device is as safe, as effective, and performs as well as the identified predicate devices. Page 4 of 4
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...